BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 228506)

  • 21. A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes.
    Vestergaard BF
    Dev Biol Stand; 1982; 52():95-8. PubMed ID: 6299863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of the genital herpes virus in the cancer of the cervix uteri].
    Thiry L; Sprecher-Goldberger S
    Bull Acad R Med Belg; 1974; 129(1 pt 2):109-41. PubMed ID: 4377231
    [No Abstract]   [Full Text] [Related]  

  • 23. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
    Aurelian L
    Cancer Res; 1974 May; 34(5):1126-35. PubMed ID: 4367156
    [No Abstract]   [Full Text] [Related]  

  • 24. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
    Aurelian L
    Clin Orthop Relat Res; 1974; (99):78-85. PubMed ID: 4363067
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of herpes simplex-associated antigens and antibodies in patients with cervical carcinoma in Buenos Aires.
    Teyssié AR; Ayerra de Holstein B; Alonio L; Distéfano A; Lucero J; Pasqualini RS; de Torres RA
    Cell Mol Biol Incl Cyto Enzymol; 1980; 26(2):123-7. PubMed ID: 6258793
    [No Abstract]   [Full Text] [Related]  

  • 26. Serological studies against herpes simplex virus types I & II in cervical carcinoma patients.
    Rajeswari N; Thyagarajan SP; Kanaklata ; Rajendran P; Subramanian S; Vaideeswaran ; Shanta V
    Indian J Pathol Microbiol; 1987 Apr; 30(2):157-62. PubMed ID: 2856216
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunofluorescence study of the presence of herpes type 1 and type 2 antigens in patients with cancer of the uterine cervix.
    Athanasiu P; Nastac E; Stoian M; Predescu E; Hozoc M
    Virologie; 1978; 29(4):251-3. PubMed ID: 219590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Formation of antibody to nucleocapsid and envelope of Herpes simplex virus hominis].
    Doerr HW; Schmitz H; Petersen EE
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):348-54. PubMed ID: 4154610
    [No Abstract]   [Full Text] [Related]  

  • 29. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. II. Uganda.
    Adam E; Sharma SD; Zeigler O; Iwamoto K; Melnick JL; Levy AH; Rawls WE
    J Natl Cancer Inst; 1972 Jan; 48(1):65-72. PubMed ID: 4347030
    [No Abstract]   [Full Text] [Related]  

  • 30. [Relationship between Herpes simplex virus type 2 and carcinoma of the uterine cervix].
    Janda J
    Cesk Gynekol; 1973 Jul; 38(6):454-60. PubMed ID: 4354419
    [No Abstract]   [Full Text] [Related]  

  • 31. [Serum HSV-2 antibody in males from high and low incidence areas of cervical cancer].
    Chen WK; Cheng L; Guo SF; Xiang JM
    Zhonghua Zhong Liu Za Zhi; 1986 May; 8(3):199-200. PubMed ID: 3017663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies to herpes simplex virus types 1 and 2: a comparative study using indirect haemagglutination in carcinoma of the cervix and in other malignant conditions.
    Freymuth F; Morel C; Longson A; Tanguy M
    Biomedicine; 1975 Sep; 23(7):271-5. PubMed ID: 182291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reaction patterns of herpes simplex virus type 1 and type 2 proteins with sera of patients with uterine cervical carcinoma and matched controls.
    Gilman SC; Docherty JJ; Clarke A; Rawls WE
    Cancer Res; 1980 Dec; 40(12):4640-7. PubMed ID: 6254649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Seroepidemiological survey of herpes simplex virus type 2 in cervical erosion women].
    Wang YG
    Zhonghua Liu Xing Bing Xue Za Zhi; 1988 Aug; 9(4):214-6. PubMed ID: 2852541
    [No Abstract]   [Full Text] [Related]  

  • 35. A nonhuman primate model for the study of the cervical oncogenic potential of herpes simplex virus type 2.
    London WT; Nahmias AJ; Naib ZM; Fuccillo DA; Ellenberg JH; Sever JL
    Cancer Res; 1974 May; 34(5):1118-21. PubMed ID: 4366986
    [No Abstract]   [Full Text] [Related]  

  • 36. [Herpetic infection].
    Savchak VI
    Sov Med; 1983; (9):65-8. PubMed ID: 6316566
    [No Abstract]   [Full Text] [Related]  

  • 37. Herpes simplex virus and human papilloma virus in the development of cervical carcinoma.
    Kaufman RH; Adam E
    Clin Obstet Gynecol; 1986 Sep; 29(3):678-92. PubMed ID: 3019599
    [No Abstract]   [Full Text] [Related]  

  • 38. A population-based seroepidemiological study of cervical cancer.
    Dillner J; Lenner P; Lehtinen M; Eklund C; Heino P; Wiklund F; Hallmans G; Stendahl U
    Cancer Res; 1994 Jan; 54(1):134-41. PubMed ID: 8261434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological response patterns to herpes virus type 2 early and late antigens in cervical carcinoma patients.
    Heise ER; Kucera LS; Raben M; Homesley H
    Cancer Res; 1979 Oct; 39(10):4022-6. PubMed ID: 225014
    [No Abstract]   [Full Text] [Related]  

  • 40. Increasing antibody titers to herpes simplex virus type 2 during follow-up of women with cervical dysplasia.
    Sprecher-Goldberger S; Thiry L; Gould I; Fassin Y; Gompel C
    Am J Epidemiol; 1973 Feb; 97(2):103-10. PubMed ID: 4347508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.